CollaGenex (CGPI) FDA PENDING Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CollaGenex (CGPI) FDA PENDING

CGPI 0.0001000

0.0%

Jul 21 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Gator II who wrote (98)	11/19/2002 9:12:43 AM
From: Gator II	of 142

This is the shortest and most cautious news story re CGPI's latest on what may prove to be their miracle drug, being equated to aspirin, Periostat. If CNBC picks this or any of the other stories up, this stock could jump several points in a New York minute considering its small float. We shall see: Dow Jones Business News CollaGenex Pharmaceuticals' Periostat May Lower CRP Levels Tuesday November 19, 8:32 am ET NEWTON, Pa. -(Dow Jones)- CollaGenex Pharmaceuticals Inc. (NasdaqNM:CGPI - News) said a pilot study showed its Periostat drug lowered levels of the C-reactive protein in people hospitalized for acute coronary syndrome. A recent study said high levels of the protein, produced by the body in response to infection and injury, could signal heart disease. In a press release Tuesday, the pharmaceutical company said it found Periostat reduced C-reactive proteins in subjects by an average of 46%. The U.S. Food & Drug Administration approved Periostat for treating adult periodontitis in 1998. Company Web site: collagenex.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next